Jonathan Stuart Kaplan

Array ( [id] => 5545410 [patent_doc_number] => 20090155287 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Modified vaccinia virus strains for use in diagnostic and therapeutic methods' [patent_app_type] => utility [patent_app_number] => 12/080766 [patent_app_country] => US [patent_app_date] => 2008-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95168 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155287.pdf [firstpage_image] =>[orig_patent_app_number] => 12080766 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5551829 [patent_doc_number] => 20090285815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-11-19 [patent_title] => 'IMMUNOCONJUGATES COMPRISING CD4 AND IMMUNOGLOBIN MOLECULES FOR THE TREATMENT OF HIV INFECTION' [patent_app_type] => utility [patent_app_number] => 12/053506 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 23650 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0285/20090285815.pdf [firstpage_image] =>[orig_patent_app_number] => 12053506 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6256870 [patent_doc_number] => 20100029568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-04 [patent_title] => 'TIGHTER-BINDING C-PEPTIDE INHIBITORS OF HIV-1 ENTRY' [patent_app_type] => utility [patent_app_number] => 12/531116 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17230 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20100029568.pdf [firstpage_image] =>[orig_patent_app_number] => 12531116 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545303 [patent_doc_number] => 20090155180 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Methods and targets for identifying compounds for regulating rhinovirus infection' [patent_app_type] => utility [patent_app_number] => 12/072731 [patent_app_country] => US [patent_app_date] => 2008-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23123 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155180.pdf [firstpage_image] =>[orig_patent_app_number] => 12072731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5435013 [patent_doc_number] => 20090169599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'SCIENTIFICALLY MODULATED AND REPROGRAMMED TREATMENT (SMART) FAS/FASL VIRUS TECHNOLOGY INTENDED TO NEUTRALIZE T-HELPER CELLS INFECTED WITH THE HUMAN IMMUNODEFICIENCY VIRUS' [patent_app_type] => utility [patent_app_number] => 11/968007 [patent_app_country] => US [patent_app_date] => 2007-12-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3904 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20090169599.pdf [firstpage_image] =>[orig_patent_app_number] => 11968007 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467317 [patent_doc_number] => 20100040614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS' [patent_app_type] => utility [patent_app_number] => 12/521302 [patent_app_country] => US [patent_app_date] => 2007-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 50206 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040614.pdf [firstpage_image] =>[orig_patent_app_number] => 12521302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5296110 [patent_doc_number] => 20090011036 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-08 [patent_title] => 'Drug containing hollow protein nanoparticles of particle-forming protein, fused with disease-treating target-cell-substance' [patent_app_type] => utility [patent_app_number] => 11/987476 [patent_app_country] => US [patent_app_date] => 2007-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 9471 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20090011036.pdf [firstpage_image] =>[orig_patent_app_number] => 11987476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530560 [patent_doc_number] => 07887813 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof' [patent_app_type] => utility [patent_app_number] => 11/932410 [patent_app_country] => US [patent_app_date] => 2007-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 25375 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/887/07887813.pdf [firstpage_image] =>[orig_patent_app_number] => 11932410 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515564 [patent_doc_number] => 20090215871 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'Simian adenovirus vectors and methods of use' [patent_app_type] => utility [patent_app_number] => 11/978477 [patent_app_country] => US [patent_app_date] => 2007-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 38158 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20090215871.pdf [firstpage_image] =>[orig_patent_app_number] => 11978477 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4879700 [patent_doc_number] => 20080153083 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-06-26 [patent_title] => 'Settings for recombinant adenoviral-based vaccines' [patent_app_type] => utility [patent_app_number] => 11/978043 [patent_app_country] => US [patent_app_date] => 2007-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 18926 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0153/20080153083.pdf [firstpage_image] =>[orig_patent_app_number] => 11978043 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7544999 [patent_doc_number] => 08052968 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Modified vaccinia virus strains for use in diagnostic and therapeutic methods' [patent_app_type] => utility [patent_app_number] => 11/975090 [patent_app_country] => US [patent_app_date] => 2007-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 95173 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/052/08052968.pdf [firstpage_image] =>[orig_patent_app_number] => 11975090 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5373704 [patent_doc_number] => 20090311265 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-17 [patent_title] => 'Human binding molecules capable or neutralizing influenze virus h5n1 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/310812 [patent_app_country] => US [patent_app_date] => 2007-09-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 73999 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20090311265.pdf [firstpage_image] =>[orig_patent_app_number] => 12310812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4954515 [patent_doc_number] => 20080187539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-07 [patent_title] => 'Method for preventing HIV-1 infection of CD4 cells' [patent_app_type] => utility [patent_app_number] => 11/894677 [patent_app_country] => US [patent_app_date] => 2007-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9330 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20080187539.pdf [firstpage_image] =>[orig_patent_app_number] => 11894677 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4533002 [patent_doc_number] => 07888112 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-02-15 [patent_title] => 'Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection' [patent_app_type] => utility [patent_app_number] => 11/892020 [patent_app_country] => US [patent_app_date] => 2007-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 37560 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/888/07888112.pdf [firstpage_image] =>[orig_patent_app_number] => 11892020 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4927422 [patent_doc_number] => 20080166785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-10 [patent_title] => 'Polynucleotides allowing the expression and secretion of recombinant HBsAg virus-like particles containing a foreign peptide, their production and use' [patent_app_type] => utility [patent_app_number] => 11/889218 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 49 [patent_figures_cnt] => 49 [patent_no_of_words] => 10830 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20080166785.pdf [firstpage_image] =>[orig_patent_app_number] => 11889218 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4807484 [patent_doc_number] => 20080171062 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-17 [patent_title] => 'Recombinant HBsAg virus-like particles containing polyepitopes of interest, their production and use' [patent_app_type] => utility [patent_app_number] => 11/889217 [patent_app_country] => US [patent_app_date] => 2007-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 65 [patent_figures_cnt] => 65 [patent_no_of_words] => 20362 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20080171062.pdf [firstpage_image] =>[orig_patent_app_number] => 11889217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4726656 [patent_doc_number] => 20080206197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Metabolically activated recombinant viral vectors and methods for their preparation and use' [patent_app_type] => utility [patent_app_number] => 11/890656 [patent_app_country] => US [patent_app_date] => 2007-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 21733 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206197.pdf [firstpage_image] =>[orig_patent_app_number] => 11890656 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6467791 [patent_doc_number] => 20100040646 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'Split-Core-Particles for the Presentation of Foreign Molecules, Especially for Vaccine Applications, and Method for their Production' [patent_app_type] => utility [patent_app_number] => 12/440454 [patent_app_country] => US [patent_app_date] => 2007-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13831 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040646.pdf [firstpage_image] =>[orig_patent_app_number] => 12440454 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5284924 [patent_doc_number] => 20090098599 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => 'Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use' [patent_app_type] => utility [patent_app_number] => 11/820496 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 41119 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20090098599.pdf [firstpage_image] =>[orig_patent_app_number] => 11820496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5501712 [patent_doc_number] => 20090162400 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-25 [patent_title] => 'Compositions of influenza viral proteins and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 11/820148 [patent_app_country] => US [patent_app_date] => 2007-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 85 [patent_figures_cnt] => 85 [patent_no_of_words] => 34744 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20090162400.pdf [firstpage_image] =>[orig_patent_app_number] => 11820148 [rel_patent_id] =>[rel_patent_doc_number] =>)